COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1151: Articles 11501-11510  | Next

Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination
Delbrueck, M., Hoehl, S., Toptan, T., Schenk, B., Grikscheit, K., Metzler, M., Herrmann, E., Ciesek, S.
10.1101/2021.11.09.21266110 — Posted: 2021-11-10
Unexposed populations and potential COVID-19 burden in European countries
Chapman, L. A. C., Barnard, R. C., Russell, T. W., Abbott, S., van Zandvoort, K., Davies, N. G., Kucharski, A. J.
10.1101/2021.11.10.21266166 — Posted: 2021-11-10 Discussion: Onsite
Phase 2 dose-ranging study of the virologic efficacy and safety of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient setting
Portal Celhay, C., Forleo-Neto, E., Eagan, W., Musser, B. J., Davis, J. D., Turner, K. C., Norton, T. D., Hooper, A. T., Hamilton, J. D., Pan, C., Mahmood, A., Baum, A., Kyratsous, C., Kim, Y., Parrino, J., Kampman, W., Roque-Guerrero, L., Stoici, R., Fatakia, A., Soo, Y., Geba, G. P., Kowal, B., DiCioccio, A. T., Stahl, N., Lipsich, L., Braunstein, N., Herman, G. A., Yancopoulos, G. D., Weinreich, D. M., Study Investigators
10.1101/2021.11.09.21265912 — Posted: 2021-11-10
Mice infected with Mycobacterium tuberculosis are resistant to secondary infection with SARS-CoV-2
Rosas Mejia, O., Gloag, E., Li, J., Ruane-Foster, M., Claeys, T. A., Farkas, D., Farkas, L., Xin, G., Robinson, R.
10.1101/2021.11.09.467862 — Posted: 2021-11-10
ChAdOx1 n-COV-19 Vaccine Side Effects Among Health Care Workers in Trinidad and Tobago
Gopaul, C. D., Ventour, D., Thomas, D.
10.1101/2021.11.09.21264627 — Posted: 2021-11-10
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN
Peetluk, L. S., Rebeiro, P. F., Edwards, K. M., Banerjee, R., Mallal, S. A., Aronoff, D. M., Lipworth, L., Katz, S. E.
10.1101/2021.11.09.21266140 — Posted: 2021-11-10
Transcriptome analysis of SARS-CoV-2 naive and recovered individuals vaccinated with inactivated vaccine
Zhang, Y., Guo, X., Li, C., Kou, Z., Lin, L., Yao, M., Pang, B., Zhang, X., Duan, Q., Tian, X., Xing, Y., Jiang, X.
10.1101/2021.11.05.467537 — Posted: 2021-11-10
A Flexible Data-Driven Framework for COVID-19 Case Forecasting Deployed in a Developing-world Public Health Setting
Jain, S., Tiwari, A., Bannur, N., Deva, A., Shingi, S., Shah, V., Kulkarni, M., Deka, N., Ramaswami, K., Khare, V., Maheshwari, H., Dhavala, S., Sreedharan, J., White, J., Merugu, S., Raval, A.
10.1101/2021.11.01.21260020 — Posted: 2021-11-10
Evidence for a long-r ange RNA-RNA interaction between ORF8 and the downstream region of the Spike polybasic insertion of SARS-CoV-2
Manzourolajdad, A., Pereira, F.
10.1101/2021.11.09.467911 — Posted: 2021-11-09
A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2
Rappaport, A. R., Hong, S.-J., Scallan, C. D., Gitlin, L., Akoopie, A., Boucher, G. R., Egorova, M., Espinosa, J. A., Fidanza, M., Kachura, M. A., Shen, A., Sivko, G., Van Abbema, A., Veres, R. L., Jooss, K.
10.1101/2021.11.08.467773 — Posted: 2021-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).